Damage to skeletal muscle tissue arising from physical exercise has been well documented in the literature (32,41,84). This phenomenon, commonly known as exercise-induced muscle damage (EIMD), occurs primarily from the performance of unaccustomed exercise, and its severity is modulated by the type, intensity, and duration of training (93). Damage can be specific to just a few macromolecules of tissue or result in large tears in the sarcolemma, basal lamina, and supportive connective tissue, and inducing injury to contractile elements and the cytoskeleton (157).
EIMD is heightened from the performance of eccentric exercise, where muscles are forcibly lengthened. Concentric and isometric exercises also contribute to EIMD, albeit to a lesser extent than eccentric training (31,51). Fast-twitch fibers are more vulnerable to eccentrically induced damage than are slow-twitch fibers (158). The possible reasons include a reduced oxidative capacity, higher levels of tension generated during training, and structural differences between fiber phenotypes (120).
The damaging effects of eccentric exercise are believed to be related to mechanical disruption of the actomyosin bonds as opposed to adenosine triphosphate–dependent detachment, which places a higher degree of stress and strain on the involved structures compared with other muscle actions (43). Because the weakest sarcomeres are located at different regions of each myofibril, it is believed that the associated nonuniform lengthening causes a shearing of myofibrils. This deforms membranes, particularly T-tubules, leading to a disruption of calcium homeostasis and consequently damage because of tearing of membranes and opening of stretch-activated channels (5). A dose-response relationship has been noted, where a greater volume of exercise results in a greater magnitude of damage (112). Symptoms of EIMD include a reduced ability to generate muscular force, increased stiffness and swelling, delayed onset muscle soreness, and an increased physiological stress response characterized by greater lactate production and an elevated heart rate response to submaximal exercise (144).
EIMD is attenuated with subsequent bouts of the same exercise stimulus (97). This phenomenon, dubbed the “repeated bout effect,” has been attributed to strengthening of connective tissue, increased efficiency in the recruitment of motor units, greater motor unit synchronization, a more even distribution of the workload among fibers, and a greater contribution of synergistic muscles (19,144). Adaptations may last for up to several months, even if no eccentric training is performed during the interim. Interestingly, the arm muscles appear to be more predisposed to EIMD than the leg muscles, leading to the supposition that susceptibility may be mollified in muscles that are used more during activities of daily living (28).
Although EIMD can have detrimental short-term effects on markers of performance and pain, it has been hypothesized that the associated skeletal muscle inflammation and increased protein turnover are necessary for long-term hypertrophic adaptations (44,160). A theoretical basis for this belief has been proposed, whereby the structural changes associated with EIMD influence gene expression, resulting in a strengthening of the tissue and thus protection of the muscle against further injury (10). Other researchers, however, have questioned this hypothesis, noting that hypertrophy can occur in the relative absence of muscle damage (19,46,86). Therefore, the purpose of this article will be twofold: (a) to review the literature and attempt to determine what, if any, role EIMD plays in promoting skeletal muscle hypertrophy and (b) to make applicable recommendations as to how lifters may use this information to optimize a hypertrophic response.
Potential Mechanisms of Action
There is a large body of evidence indicating EIMD is associated with factors involved in the accretion of muscle proteins. Research shows that muscle regeneration and repair subsequent to damaging exercise is coordinated by novel transcriptional programs involving clusters of genes that regulate inflammatory processes, growth, stress response, and membrane biosynthesis (92). The following is an overview of these aspects as they relate to EIMD.
Signaling Via Inflammatory Cells
The response to myodamage has been likened to the acute inflammatory response to infection (130). Once damage is perceived by the body, neutrophils migrate to the area of trauma, and agents are then released by damaged fibers that attract macrophages to the region of injury (96). These inflammatory cells consequently secrete other agents to damaged tissue to facilitate repair and regeneration. Inflammatory processes can have either a beneficial or detrimental effect on muscle function depending on the magnitude of the response, previous exposure to the applied stimulus, and injury-specific interactions between the muscle and inflammatory cells (148).
Neutrophils, often referred to as phagocytic cells, are the most abundant type of white blood cells in the human body. In addition to possessing phagocytic capabilities, neutrophils also secrete proteases that assist in degrading cellular debris produced by EIMD and releasing cytolytic and cytotoxic molecules that can increase damage to injured muscle and cause damage to healthy neighboring tissues (148). Thus, their primary role appears to be restricted to myolysis and other aspects involved in the removal of cellular debris rather than promoting hypertrophic supercompensation of muscle tissue.
Although there is a lack of current evidence supporting a role for neutrophils in muscle growth, it is conceivable that they may be responsible for signaling other inflammatory cells necessary for muscle regeneration. One such possibility involves reactive oxygen species (ROS) (155), which can function as key cellular signaling molecules in the response to exercise (53,76,77,145). Neutrophils are capable of producing a variety of ROS including superoxide, hydrogen peroxide, hypochlorous acid, and hydroxyl radical (79). ROS have been shown to promote growth in both smooth muscle and cardiac muscle (140), and it is theorized to have similar hypertrophic effects on skeletal muscle (141). Transgenic mice with suppressed levels of selenoproteins, a class of proteins that function as potent antioxidants, display increased exercise-induced muscle growth, potentially indicating an ROS-mediated hypertrophic effect through redox sensitive signaling pathways (69).
Hypertrophic effects associated with ROS may be carried out through heightened mitogen-activated protein-kinase (MAPK) signaling. In vitro analysis has shown that treatment of C2 myoblasts with an ROS variant increases MAPK activation, with the response of the various MAPK subfamilies (extracellular signal-regulated kinase [ERK] 1/2, JNK, and p38-MAPK) differing over time (78). Eccentric actions have, in fact, been shown to increase MAPK activation to a greater extent than concentric or isometric actions (92,94), suggesting a possible contribution from ROS activity. ROS also may modulate protein synthesis via enhanced insulin-like growth factor (IGF-1) signaling. In vitro analysis by Handayaningsih et al. (61) showed that IGF-I induced phosphorylation of the IGF-I receptor in C2C12 myocytes treated with ROS, whereas this action was markedly blunted with treatment of antioxidants, suggesting that ROS have a critical function in the biological action of IGF-I.
On the other hand, ROS have been found to have a negative effect on various serine-threonine phosphatases, including calcineurin. ROS activity can interfere with calcineurin activation by blocking its calmodulin-binding domain (25). Calcineurin is purported to play a role in both muscle hypertrophy (40,99) and fiber phenotype transformation (115), and thus, its inhibition may have a negative impact on muscle growth. Furthermore, some researchers have failed to show that ROS are involved in muscle damage pursuant to resistance training (129). Ultimately, the effects of ROS on muscle development may be dependent on the mode of exercise (i.e., anaerobic vs. aerobic), the species of ROS produced, and perhaps other factors. Further investigation is needed to elucidate their precise role in muscle development.
As opposed to neutrophils, there is a large body of evidence that suggests a role for macrophages in muscle regeneration and growth after EIMD (148), and some researchers have hypothesized that they are required for compensatory hypertrophy (79). Macrophages appear to mediate hypertrophy through the secretion of various anabolic agents, with cytokines emerging as a particularly important player in this process. Research suggests that cytokines synthesized within skeletal muscle (a.k.a. myokines) significantly contribute to the hypertrophic response (110,121,134). Numerous myokines have been identified in the literature including interleukin (IL)-6, IL-7, IL-8, IL-10, IL-13, IL-15, fibroblast growth factor (FGF), leukemia inhibitory factor (LIH), and tumor necrosis factor, among others. Each of these agents exerts its effects in an autocrine-paracrine fashion to bring about unique effects on skeletal muscle adaptation, and intense exercise appears to potentiate their response.
Early evidence showed that the production of myokines was related to myodamage (20,118). This seems logical given that cytokines are known to be involved in the response to inflammation manifesting from EIMD. However, the results of subsequent research suggest that myokine production may be largely independent of damage to muscle tissue. In a study of 20 young and elderly participants, Toft et al. (150) found that 60 minutes of eccentric cycle ergometry produced only modest increases in IL-6 relative to increases in creatine kinase (CK) levels, indicating a only a weak correlation between muscle damage and IL-6 production. Other studies have shown that the time course of CK and IL-6 are not well correlated (35), leading to speculation that the release of this myokine is primarily related to contraction of muscle fibers, perhaps as a means to mobilize substrate from fuel depots so that glucose homeostasis is maintained during intense exercise (45).
It should be noted, however, that only IL-6 and IL-8 appear to be released from muscle in the absence of damaging exercise (27). Conversely, systemic IL-15 levels and IL-15 mRNA in skeletal muscle are substantially increased after eccentric resistance exercise, not concentric exercise, and these elevations are believed to be dependent on the manifestation of tissue damage (20,122). This is important because IL-15 has been shown to be a potent mediator of muscle mass, acting directly on differentiated myotubes to increase muscle protein synthesis and reduce protein degradation (110,121). Furthermore, studies show that eccentric exercise preferentially upregulates FGF activity. The FGFs are powerful proliferative agents that are involved in inducing myofiber hypertrophy and regulating satellite cell function (161,162). The FGF has been shown to be released directly from damaged fibers (30), and the time course of its release parallels an increase in CK levels associated with EIMD (29). These findings seem to suggest that myodamage does in fact contribute to the growth process.
Satellite Cell Activity
Another possible means by which EIMD may augment muscle hypertrophy is via an increase in satellite cell activity. Satellite cells, which reside between the basal lamina and sarcolemma of muscle fibers, are believed to play a critical role in the regulation of muscular growth (64,124). In a cluster analysis, after a 16-week resistance training protocol, Petrella et al. (119) demonstrated that subjects who experienced extreme increases in mean myofiber cross-sectional area of the vastus lateralis (>50%) possessed a much greater ability to expand the satellite cell pool compared with those who experienced moderate or negligible increases in hypertrophy. These results are consistent with those of studies showing that muscle hypertrophy is significantly limited when satellite cells are obliterated by gamma irradiation (124,156).
Satellite cells remain quiescent until being aroused by a mechanical stimulus imposed on skeletal muscle (157). Once activated, they generate precursor cells (myoblasts) that proliferate and ultimately fuse to existing cells, providing agents needed for repair and subsequent growth of new muscle tissue (151,165). This may involve the coexpression of various myogenic regulatory factors such as Myf5, MyoD, myogenin, and MRF4 (34), which bind to sequence-specific DNA elements present in the promoter of muscle genes, aiding in the hypertrophic process (127,136).
Satellite cells also help to retain the mitotic capability of muscles by donating their nuclei to existing muscle fibers, thereby increasing the capacity to synthesize new contractile proteins (12,104). Because a muscle's nuclear-content-to-fiber-mass ratio remains constant during hypertrophy, the satellite cell-derived addition of new myonuclei is believed to be essential for realizing long-term increases in muscle mass (149). This is consistent with the concept of myonuclear domain, which proposes that the myonucleus regulates mRNA production for a finite sarcoplasmic volume, and any increases in fiber size must be accompanied by a proportional increase in myonuclei (119).
The interplay between muscle damage and satellite cell activity has been well established in the literature (38,126,131). Damaged fibers must quickly obtain additional myonuclei to facilitate reparation; if not, they would face cell death and thus compromise the body's functional ability. Thus, when exercised fibers sustain damage, satellite cells proliferate and adhere to the damaged fiber as a means to initiate repair. Given that area under the myoneural junction contains a high population of satellite cells (66,136), it is theorized that neurons innervating damaged fibers might further help to stimulate satellite cell activity, enhancing the regenerative response (157). Some researchers have proposed that a threshold of myodamage may exist beyond which stimulated satellite cells fuse to each other to form new myofibers (11), although this remains speculative.
The initial signal for damage-induced satellite cell activation is believed to originate from muscle-derived nitric oxide, possibly in conjunction with hepatocyte growth factor secretion (3,143,148). The process is thought to be regulated, at least in part, by the cyclooxygenase (COX)-2 pathway, which has been deemed as necessary to achieve maximal skeletal muscle hypertrophy in response to functional overload (137). The COX-2 exerts its effects by mediating the synthesis of various prostaglandins known to stimulate satellite cell proliferation, differentiation, and fusion (16). The inflammatory response to EIMD is believed to play a crucial role in this regenerative response, as myogenesis has been shown to be enhanced when inflammatory cells are abundant and impaired in their absence (16). The hypertrophic importance of exercise-induced inflammation is further supported by research showing that nonsteroidal anti-inflammatory drugs (NSAIDs), which inhibit COX-2, blunt the satellite cell response (8). Most (16,17,91,100), but not all (117), studies have found significant decreases in satellite cell activity when NSAIDs were administered in response to muscle damage (Table 1), thereby potentially limiting long-term load-induced increases in muscle hypertrophy.
It should be noted that mechanical stimuli alone can initiate satellite cell proliferation and differentiation without subsequent damage to muscle tissue (109,159). Therefore, it remains to be determined whether the effects of EIMD are additive or redundant in terms of maximizing one's hypertrophic potential.
Insulin-Like Growth Factor–1 Signaling
IGF-1 is an anabolic hormone that, as the name implies, has structural properties similar to those of insulin. A clear cause and effect relationship has been established between IGF-1 and skeletal muscle hypertrophy, with both mitogenic and anabolic effects seen in muscle tissue (59). Although IGF-1 plays a general role in anabolism under normal physiological conditions, its anabolic effects on muscle are thought to be enhanced in response to mechanical loading (18,60). Some consider it to be the major extracellular mediator of skeletal muscle growth (128), and there is evidence that it may be necessary for compensatory hypertrophy (59).
Several IGF-1 isoforms have been identified including the systemic forms IGF-1Ea and IGF-1Eb, and the muscle-specific IGF-1Ec, which has been termed mechano growth factor (MGF) and is believed to be the isoform principally responsible for compensatory hypertrophy (114). These isoforms are involved in the transduction of multiple anabolic signaling pathways. For one, IGF-1 is involved in the MAPK signaling, particularly via the ERK cascade. Haddad and Adams (59) demonstrated that coinfusion of a MAPK/ERK inhibitor prevented an increase in IGF-1-mediated protein synthesis, apparently via reduced S6K1 phosphorylation. These results highlight the importance of IGF-1/MAPK/ERK signaling cascade in the regulation of muscle growth. As discussed, MAPK signaling has been shown to be highly active during eccentric exercise. Whether this is mediated by IGF-1 system is not entirely clear at this time.
IGF-1 also has been implicated in various Ca2+-dependent pathways shown to stimulate L-type calcium channel gene expression, leading to an increased intracellular Ca2+ concentration (105). This in turn instigates the activation of calcineurin, a Ca2+-sensitive phosphatase that plays an important regulatory role in muscle adaptation via the expression of various downstream signaling targets including nuclear factor of activated T-cells and GATA-2 (133,147). Levels of the striated muscle activator of Rhos signaling (STARS) gene, a muscle-specific transducer for intracellular signaling sensitive to calcineurin, are increased 10-fold after EIMD suggesting that STARS may be an important downstream target in the early signaling for skeletal muscle remodeling (92). The precise effects of calcineurin in muscle development remains in question. Although some studies suggest that calcineurin has a significant effect on muscular growth (40,99), others indicate its primary role is in the regulation of fiber phenotype, that is, type I, IIA, or IIX (115). Recent research suggests that calcineurin may have a selective hypertrophic effect on slow-twitch muscle fibers (13,128), raising uncertainty over its role in regeneration after EIMD.
In addition, IGF-1 is known to influence the mammalian target of rapamycin (mTOR) pathway. This is important because mTOR is widely considered a master network for controlling skeletal muscle growth (15,54,75,146). IGF-1 mediates mTOR activity via phosphatidylinositol 3-kinase (PI3K)/Akt, an upstream molecular nodal point that both facilitates anabolic signaling and inhibits catabolic signals (106,151). The binding of IGF-1 to its receptor triggers the activation of PI3K, leading to the phosphorylation of Akt. Akt, in turn, signals mTOR, which then exerts effects on various downstream targets including p70S6k to promote muscle protein synthesis through increases in translation initiation and elongation (15). It should be noted that recent research suggests that resistance exercise can activate mTOR independently of PI3K/Akt, presumably under the control of phosphatidic acid and the ERK/TSC2 pathway (68,70,102,113). With respect to EIMD, some studies have found that phosphorylation of Akt is significantly greater in eccentric contractions compared with isometric contractions (125), whereas others show it remains unaffected regardless of contraction type (42). It therefore remains unclear what, if any, role this pathway has in regeneration after EIMD.
Another means by which IGF-1 promotes anabolism is by increasing the protein synthetic rate in differentiated myofibers (12,60). Locally expressed MGF has been shown to activate satellite cells and mediate their proliferation and differentiation (67,163). Systemically produced IGF-IEa, on the other hand, has been shown to upregulate fusion of satellite cells with existing muscle fibers, facilitating the donation of myonuclei and helping to maintain optimal DNA-to-protein ratios in muscle tissue (151,156).
A number of studies have reported that EIMD potentiates IGF-1 production and thereby enhances the hypertrophic response to exercise. For example, Bamman et al. (9) showed that eccentric exercise increased IGF-1 mRNA concentrations by 62% while decreasing levels of IGFBP-4 mRNA—a strong inhibitor of IGF-1—by 57%. Concentric exercise produced negligible changes in these markers, indicating that structural damage to the muscle was responsible for the activation of IGF-1 system.
McKay et al. (98) studied the in vivo response of all 3 IGF-1 isoforms to a protocol specifically designed to bring about damage in human skeletal muscle. Eight healthy male participants performed a series of 300 lengthening contractions of the knee extensors. MGF mRNA increased significantly 24 hours after the intervention, while the expression of both IGF-1Ea and IGF-1Eb mRNA were not elevated until 72 hours postintervention. Because MGF expression was found to occur earlier than other IGF-1 splice variants, researchers speculated that this isoform may have a distinct role in the reparation process subsequent to EIMD.
Not all studies have found an association between IGF-1 production and EIMD, however. Garma et al. (49) evaluated the acute effects of eccentric, concentric, and isometric actions on anabolic signaling in rodents. The protocol was designed so that volume of accumulated force was equated between exercise conditions. Nearly identical results were found in the anabolic response of the 3 modes of contraction, including no differences in IGF-1 mRNA levels. The reason for discrepancies between studies is not readily apparent and requires further investigation.
A novel theory by which EIMD may contribute to muscle hypertrophy is via an increase in intracellular water content. This phenomenon, known as cell swelling, serves as a physiological regulator of cell function (63), stimulating anabolic processes both by increasing protein synthesis and decreasing protein breakdown (56,101,139). It has been proposed that increased pressure against the cytoskeleton and cell membrane is perceived as a threat to cellular integrity, which in turn causes the cell to initiate a signaling response that ultimately leads to reinforcement of its ultrastructure (85,130).
The exact mechanisms by which cellular swelling promotes anabolism have not been fully elucidated. There is evidence that integrin-associated volume sensors located within cells are involved in the process (87). When the membrane is subjected to swelling-induced stretch, these sensors activate anabolic protein-kinase transduction pathways in muscle, possibly mediated by autocrine effects of growth factors (30). This may also have a direct effect on amino acid transport systems. PI3K appears to be an important signaling component in modulating glutamine and methylaminoisobutyric acid transport in muscle because of increased cellular hydration (87). In addition, the stimulus associated with cell swelling may trigger proliferation of satellite cells and facilitate their fusion to hypertrophying myofibers (36).
The inflammatory response after EIMD is characterized by an accumulation of fluid and plasma proteins within the affected tissue to an extent whereby this buildup exceeds the capacity of lymphatic drainage resulting in swelling (58,96,120). Associated damage to capillaries may augment the degree of edema (32). Howell et al. (72) found that an acute bout of eccentric exercise for the elbow flexors in untrained subjects led to a swelling-induced increase in arm circumference of as much as 9%, with values remaining elevated for as long as 9 days. Using a similar protocol, Nosaka and Clarkson (111) reported up to a 4.3-cm increase in arm circumference attributed to edema, with swelling conspicuous in all the subjects by 3 days postexercise. Although these effects are attenuated with regimented exercise via the repeated bout effect, significant swelling nevertheless persists even in trained subjects with increases in muscle girth seen 48 hours postworkout (71).
To date, no study has directly evaluated the effects of EIMD-mediated cell swelling on muscle growth. NSAID administration, which reduces the inflammatory response and thus diminishes cell swelling, has been shown in some studies to impair the increase in muscle protein synthesis normally associated with resistance exercise (152). It is possible that these negative hypertrophic effects may be attributable to a reduction in cellular hydration. However, a cause-effect relationship between inflammatory-derived cell swelling and protein accretion cannot be established based on this data, and results conceivably could be related to confounding factors such as reduced satellite cell and macrophage activity. Further study is needed to investigate this theory.
Research Examining the Relationship Between EIMD and Hypertrophy
Despite the apparently sound theoretical rationale, a direct cause-effect relationship is yet to be established between EIMD and increased muscle growth. The following section will discuss what is known from the literature based on studies evaluating the hypertrophic effects of protocols designed to induce myodamage.
To date, few experimental studies have directly attempted to determine if a causal relationship exists between EIMD and muscle hypertrophy (Table 2). Komulainen et al. (80) investigated the hypothesis that severe exercise-induced damage results in greater muscle hypertrophy compared with minor damage. Wistar rats were subjected to repeated shortening (S) or lengthening (L) contractions of the tibialis anterior muscles. After 8 days postexercise, the rats in the L group displayed a 7.1-fold increase in muscle damage (measured by beta-glucuronidase activity) compared with a 2.6-fold increase in the S group. At the conclusion of the study, increases in muscle cross-sectional area were found to be similar between groups. These results appear to indicate that a threshold exists beyond which damage does not have any further effect on hypertrophy. A drawback to the study is that varying degrees of damage were not studied, making it impossible to know whether a dose-response relationship may exist at more moderate levels of EIMD. Moreover, these results are only applicable to early stage training adaptations, as the repeated bout effect would preclude excessive muscle damage in well-trained individuals.
Recently, Flann et al. (46) sought to determine whether muscle damage enhanced muscle hypertrophy in untrained human subjects. The participants were divided into 2 groups: (a) a naive group (NA) performed eccentric exercise on an ergometer at a “somewhat hard” level (as determined by a rating of perceived exertion scale). Training was carried out 3 times a week for 20 minutes over an 8 week period, and (b) a pretrained group (PT) performed the identical protocol to NA, except training for these subjects included a “ramp up” period lasting 3 weeks that employed low-intensity exercise to gradually acclimate their muscles to the protocol. At the end of the study period, no statistically significant differences in muscle girth were noted between groups.
Although these results are intriguing, several methodological limitations make it difficult to draw relevant conclusions on the topic. First, the PT group trained for a total of 11 weeks compared with only 8 weeks for the NA group. The authors stated that this issue was addressed by adjusting workload so that subjects in both groups performed the same cumulative training over the course of the study. The hypertrophic effects of packing more exercise into a shorter time period in untrained subjects is not clear, however, and it is difficult to assess whether this may have impacted results.
Second, both groups performed eccentric exercise throughout the protocol making it likely that the PT group actually experienced some degree of muscle damage from the training. The CK analysis did in fact show evidence of EIMD in the PT group, although it was significantly lower than that experienced by those in the NA group. Thus, it may be that the amount of damage sustained by the PT group was sufficient for eliciting a maximal hypertrophic response or perhaps that the damage sustained by the NA group was excessive and ultimately attenuated gains by reducing their ability to train with sufficient intensity and/or delaying supercompensatory adaptations.
Third, the study was underpowered, thereby raising the possibility of a type II error. A hypertrophic advantage was actually noted for the NA group compared with the PT group (7.5% vs. 6.5%, respectively), but the results did not reach statistical significance. Whether these results would have been significant with an adequately powered study is not clear. The possibility also exists that had the study lasted longer, the difference may have become statistically significant.
Finally, the participants had no prior training experience, limiting generalizability to untrained individuals. It is possible that the stimulus for hypertrophy is different between trained and untrained individuals, and that adaptive responses related to EIMD may become more important as one gains training experience. Further research is warranted to address these limitations and provide more definitive evidence as to whether EIMD contributes to muscle hypertrophy in various populations.
A recent meta-analysis indicates that eccentric exercise is superior for inducing gains muscle mass compared with concentric exercise. Roig et al. (123) evaluated 3 studies encompassing 73 subjects and found that eccentric exercise produced statistically significant greater increases in muscle girth compared with concentric exercise. Moreover, the researchers noted that 2 of the 3 studies not included in the analysis underscored the superiority of eccentric exercise in maximizing hypertrophy. In support of these findings, it has been proposed that optimal exercise-induced muscle growth is not attained unless eccentric muscle actions are performed (62).
That said, several studies have failed to show any hypertrophic benefit associated with eccentric actions (4,103) and there is even some research indicating that concentric training may in fact promote greater muscle growth (95). These inconsistencies may be caused at least in part by methodological differences between studies, and the possibility remains that the hypertrophic advantage of eccentric exercise is nullified when protocols equate for volume load. When the body of literature is considered, however, eccentric resistance training does appear to elicit greater hypertrophic gains compared with other muscle actions.
There is evidence that eccentrically induced hypertrophy may include sarcomerogenesis, as several studies have reported a serial increase in sarcomeres associated with lengthening actions. Lynn et al. (89) showed that rats exposed to downhill running had an increase in sarcomere count compared with a group that ran uphill. The downhill group displayed a smaller shift in the optimal torque angle, potentially indicative of reduced muscle damage. Similar findings have been noted by other researchers in both rodent and human subjects (23,88,164). These results are believed to be a protective response whereby the average sarcomere length is decreased at a given muscle length so that less of the muscle's working range includes the region of instability during future eccentric actions (120). Research seems to indicate, however, that sarcomerogenesis is limited to the first few weeks of exercise and ceases to occur thereafter (14,135).
Nosaka et al. (112) proposed that EIMD promotes muscle hyperplasia rather than muscle hypertrophy. Although this is an intriguing hypothesis, studies reporting evidence of hyperplasia in animal models have been called into question, with results attributed to a miscounting of the intricate arrangements of elongating fibers as a greater fiber number (116). Evidence that hyperplasia occurs in human subjects is lacking at this time (2,90). Further research is needed to determine if damage to tissue can, in fact, promote splitting of myofibers and thus an increase in the number of fibers within a muscle.
Is There a Causal Link Between EIMD, Eccentric Exercise, and Hypertrophy?
Given that eccentric exercise causes EIMD, a logical assumption is that the damage to tissue may be responsible for its additional growth promoting effects. Although this presents an enticing hypothesis, the underlying logic has been challenged by a number of researchers. The following section will detail potential issues with EIMD hypothesis and discuss proposed alternative hypotheses that attempt to explain the hypertrophic advantages of eccentric exercise.
Challenges to EIMD Hypothesis
Some researchers have questioned the validity of EIMD hypothesis based on the fact that muscles become increasingly less susceptible to damage with repeated exercise (112). As discussed, a repeated bout effect has been consistently reported whereby EIMD is attenuated after a single bout of exercise and becomes increasingly less prevalent thereafter. This observation would suggest that damage does not contribute to training-induced muscle hypertrophy. A problem with this theory, however, is that EIMD persists even in well-trained subjects, albeit to a lesser degree than in novice trainees. Gibala et al. (50) studied the response of 6 strength trained men to the performance of 8 sets of 8 repetitions at a load equivalent to 80% of their concentric 1-repetition maximum. Training was carried out unilaterally so that one arm performed only concentric actions while the other arm performed only eccentric actions. Muscle biopsy obtained 21 hours postexercise revealed a significantly greater fiber disruption in the eccentrically trained arm compared with the concentrically trained armed. These results highlight the fact that the repeated bout effect only attenuates the extent of myodamage rather than preventing its occurrence. Thus, the possibility that damage may in fact play a role in the hypertrophic response cannot be ruled out based solely on the repeated bout effect.
Another claim made to refute a potential role for EIMD in muscle hypertrophy is that low-intensity occlusion training produces marked hypertrophy with apparently minimal damage to muscle (1,141). This method of exercise, called Kaatsu, employs light loads (20–50% of 1RM) using a pressure cuff to create a hypoxic environment. After several months of training, hypertrophic gains have been reported to be approximately equal to those seen with traditional “hypertrophy” loads of 70–80% 1RM. Given that the very light loading employed in Kaatsu training would seemingly minimize disruption of myofibers, this would suggest the lack of a cause-effect relationship. It should be noted, however, that muscle damage is a known consequence of reperfusion subsequent to ischemia (47,57). Takarada et al. (141) found that although markers of muscle damage were indeed lower after Kaatsu training, there nevertheless was evidence of fine microdamage within muscle tissue. Thus, the potential exists that damage may have contributed to results. Perhaps more importantly, it is not clear whether hypertrophy would have been more pronounced had an even greater amount of EIMD been present in the Kaatsu group. Future protocols should seek to address these issues.
Finally, some researchers question whether a correlation exists between EIMD and hypertrophy based on findings that aerobic exercise such as downhill running can cause significant damage to muscle tissue without corresponding growth (19). This observation, however, fails to account for the fact that aerobic exercise and resistance exercise elicit unique molecular responses, activating and suppressing a distinctly different subset of genes and cellular signaling pathways (65). Atherton et al. (6) found that the body has an “AMPK-PKB switch” whereby signaling is switched to either a catabolic AMPK/PGC-1α- or anabolic PKB-TSC2-mTOR–dominated state depending on whether the imposed demand is endurance or resistance based. Specifically, aerobic training is associated with the activation of AMPK and its various downstream targets including PGC-1α, which have been shown to mediate mitochondrial biogenesis and progression toward a slower muscle phenotype while impairing contractile protein synthesis (7,138). The catabolic effects of this signaling cascade remain well into the postexercise period, suppressing phosphorylation of PKB or other downstream targets associated with protein synthesis (37,52,154). Resistance training, on the other hand, promotes anabolism through a variety of signaling pathways. Although AMPK is activated during the performance of resistance exercise, these effects are reversed immediately post–workout, with signaling rapidly switched to bring about a highly anabolic state (39). Thus, one can infer that muscle damage by itself is not sufficient to override catabolic signaling and, if EIMD does in fact play a role in hypertrophic remodeling, it can only do so in the presence of resistance-based mechanical overload.
Interestingly, the damage induced by aerobic exercise manifests differently from that of anaerobic training. The CK activity has been shown to peak approximately 12–24 hours postexercise after downhill running while that associated with resistance training does not manifest until after about 48 hours and can peak 4–6 days postexercise (132). Moreover, peak CK levels associated with downhill running range from 100 to 600 IU, whereas resistance training produces levels ranging from 2,000 to 10,000 IU (33). The implications of these discrepancies are yet to be elucidated. It also should be noted that CK levels do not necessarily reflect the degree or time course of muscle damage (32).
If muscle damage is not responsible for the increased hypertrophy associated with eccentric resistance exercise, the question then arises as to what mechanisms account for these effects. A common hypothesis posits that results may be a function of a selective recruitment of fast-twitch muscle fibers, whereby a greater amount of tension is assumed by a reduced number of fibers. Several electromyography (EMG) studies have indicated a reversal of Henneman's size principle of recruitment during eccentric training, whereby the larger fast-twitch fibers are preferentially accessed to carry out exercise performance (73,107,108). This seems to be consistent with the findings of research showing that lengthening actions increase p70S6k in fast-twitch fibers but not in slow-twitch fibers (142). Given that fast-twitch fibers have a significantly greater potential for growth (81,153), it is feasible that this could potentially account for the greater protein accretion seen in eccentric protocols. Other studies, however, seem to refute whether a reversal of the size principle actually does occur. An extensive review of the literature by Chalmers (26) concluded that the preponderance of evidence does not support selective recruitment of fast-twitch fibers during eccentric contractions. These results held constant in 9 out of 10 studies deemed suitable to address the topic and were applicable over a wide range of efforts and speeds.
Another alternative hypothesis proposes that hypertrophic benefits associated with eccentric exercise may be due to a greater imposed mechanical stress compared with concentric or isometric actions (112). Indeed, muscles are capable of generating greater absolute force when contracting eccentrically vs. concentrically (123). Despite this fact, however, muscle activation during maximal eccentric actions is generally less compared with those performed concentrically. This paradox was demonstrated by Grabiner et al. (55), who found that the maximum EMG of the vastus lateralis during eccentric knee extension was only 84 ± 41% of that obtained concentrically. Hence, although the potential to exert peak force is greater with eccentric exercise, most find it extremely difficult to achieve the maximum force during eccentric actions, ultimately resulting in an incomplete activation of the spectrum of motor neurons for a given working muscle (43).
Perhaps more importantly, the use of absolute maximal loads is not necessarily paramount for optimal muscle growth. Although mechanical force appears to be the primary stimulus for eliciting hypertrophic gains, there is evidence that a threshold may exist beyond which other factors predominate (130). Hypertrophy-oriented routines traditionally employ submaximal intensities, with loads in the range of 65–85% 1RM (24,74,82). Fry (48) determined that the optimum load for muscle growth was in the upper range of these values—a figure still well below concentric maximum. Further support for this stance can be found in studies showing that protocols using submaximal loads produce increases in anabolic signaling and protein synthesis greater than or equal to protocols that employ high-intensity loads of >90% 1RM (22,74). Thus, the theory that the hypertrophic superiority of eccentric actions is solely a function of higher force output remains speculative at this time.
There is a sound theoretical rationale supporting a potential role for EIMD in the hypertrophic response. Although it appears that muscle growth can occur in the relative absence of muscle damage, potential mechanisms exist whereby EIMD may enhance the accretion of muscle proteins including the release of inflammatory agents, activation of satellite cells, and upregulation of IGF-1 system, or at least set in motion the signaling pathways that lead to hypertrophy. Although research suggests that eccentric exercise has greater hypertophic effects compared with other types of actions, a cause-effect relationship directly linking these gains to EIMD is yet to be established. Moreover, if such a relationship does in fact exist, it is not clear as to what extent of damage is optimal for inducing maximum muscle growth.
Evidence does seem to show that a threshold exists beyond which damage does not further augment muscle remodeling and may in fact interfere with the process. Given that a high degree of EIMD causes a reduction in the force-producing ability of the affected muscle, excessive damage can impair an individual's ability to train, which necessarily would have a detrimental effect on muscle growth. Moreover, while training in the early recovery phase of EIMD does not seem to exacerbate muscle damage, it may interfere with the recovery process (83,112). Thus, the current research indicates that a protocol that elicits a moderate amount of damage would be most appropriate for maximizing the hypertrophic response.
Future research should seek to clarify whether a causal relationship exists between EIMD and muscle hypertrophy and, if so, evaluate optimal levels of damage to maximize the response. Furthermore, the vast majority of studies have been carried out on untrained subjects. Considering that a ceiling effect slows the rate of muscle growth as one gains training experience, it is possible that myodamage may become an increasingly important mediator of hypertrophy in highly trained individuals. Elucidating these issues will help to increase our understanding of the mechanisms of muscle development and allow for the optimization hypertrophy-oriented training programs.
1. Abe T, Yasuda T, Midorikawa T, Sato Y, Kearns C, Inoue K, Koizumi K, Ishii N. Skeletal muscle size and circulating IGF-1 are increased after two weeks of twice daily KAATSU resistance training. Int J Kaatsu Training Res 1: 6–12, 2005.
2. Abernethy PJ, Jurimae J, Logan PA, Taylor AW, Thayer RE. Acute and chronic response of skeletal muscle to resistance exercise. Sports Med 17: 22–38, 1994.
3. Adams G. The molecular response of skeletal muscle to resistance training. Deutsche Zeitschr Sportmed 61: 61–67, 2010.
4. Adams GR, Cheng DC, Haddad F, Baldwin KM. Skeletal muscle hypertrophy in response to isometric, lengthening, and shortening training bouts of equivalent duration. J Appl Physiol 96: 1613–1618, 2004.
5. Allen DG, Whitehead NP, Yeung EW. Mechanisms of stretch-induced muscle damage in normal and dystrophic muscle: Role of ionic changes. J Physiol 567: 723–735, 2005.
6. Atherton PJ, Babraj J, Smith K, Singh J, Rennie MJ, Wackerhage H. Selective activation of AMPK-PGC-1alpha or PKB-TSC2-mTOR signaling can explain specific adaptive responses to endurance or resistance training-like electrical muscle stimulation. FASEB J 19: 786–788, 2005.
7. Baar K. Involvement of PPAR gamma co-activator-1, nuclear respiratory factors 1 and 2, and PPAR alpha in the adaptive response to endurance exercise. Proc Nutr Soc 63: 269–273, 2004.
8. Bamman MM. Take two NSAIDs and call on your satellite cells in the morning. J Appl Physiol 103: 415–416, 2007.
9. Bamman MM, Shipp JR, Jiang J, Gower BA, Hunter GR, Goodman A, McLafferty CL Jr, Urban RJ. Mechanical load increases muscle IGF-I and androgen receptor mRNA concentrations in humans. Am J Physiol Endocrinol Metab 280: E383–E390, 2001.
10. Barash IA, Mathew L, Ryan AF, Chen J, Lieber RL. Rapid muscle-specific gene expression changes after a single bout of eccentric contractions in the mouse. Am J Physiol Cell Physiol 286: C355–C364, 2004.
11. Barton ER, Morris L, Musaro A, Rosenthal N, Sweeney HL. Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol 157: 137–148, 2002.
12. Barton-Davis ER, Shoturma DI, Sweeney HL. Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle. Acta Physiol Scand 167: 301–305, 1999.
13. Bassel-Duby R, Olson EN. Signaling pathways in skeletal muscle remodeling. Annu Rev Biochem 75: 19–37, 2006.
14. Blazevich AJ, Cannavan D, Coleman DR, Horne S. Influence of concentric and eccentric resistance training on architectural adaptation in human quadriceps muscles. J Appl Physiol 103: 1565–1575, 2007.
15. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3: 1014–1019, 2001.
16. Bondesen BA, Mills ST, Kegley KM, Pavlath GK. The COX-2 pathway is essential during early stages of skeletal muscle regeneration. Am J Physiol Cell Physiol 287: 475–483, 2004.
17. Bondesen BA, Mills ST, Pavlath GK. The COX-2 pathway regulates growth of atrophied muscle via multiple mechanisms. Am J Physiol Cell Physiol 290: 1651–1659, 2006.
18. Brahm H, Piehl-Aulin K, Saltin B, Ljunghall S. Net fluxes over working thigh of hormones, growth factors and biomarkers of bone metabolism during short lasting dynamic exercise. Calcif Tissue Int 60: 175–180, 1997.
19. Brentano MA, Martins Kruel LF. A review on strength exercise-induced muscle damage: Applications, adaptation mechanisms and limitations. J Sports Med Phys Fitness 51: 1–10, 2011.
20. Bruunsgaard H. Physical activity and modulation of systemic low-level inflammation. J Leukoc Biol 78: 819–835, 2005.
21. Bruunsgaard H, Galbo H, Halkjaer-Kristensen J, Johansen TL, MacLean DA, Pedersen BK. Exercise-induced increase in serum interleukin-6 in humans is related to muscle damage. J Physiol 499(Pt 3): 833–841, 1997.
22. Burd NA, West DW, Staples AW, Atherton PJ, Baker JM, Moore DR, Holwerda AM, Parise G, Rennie MJ, Baker SK, Phillips SM. Low-load high volume resistance exercise stimulates muscle protein synthesis more than high-load low volume resistance exercise in young men. PLoS One 5: e12033, 2010.
23. Butterfield TA, Leonard TR, Herzog W. Differential serial sarcomere number adaptations in knee extensor muscles of rats is contraction type dependent. J Appl Physiol 99: 1352–1358, 2005.
24. Campos GER, Luecke TJ, Wendeln HK, Toma K, Hagerman FC, Murray TF, Ragg KE, Ratamess NA, Kraemer WJ, Staron RS. Muscular adaptations in response to three different resistance-training regimens: Specificity of repetition maximum training zones. Eur J Appl Physiol 88: 50–60, 2002.
25. Carruthers NJ, Stemmer PM. Methionine oxidation in the calmodulin-binding domain of calcineurin disrupts calmodulin binding and calcineurin activation. Biochemistry (NY) 47: 3085–3095, 2008.
26. Chalmers GR. Can fast-twitch muscle fibres be selectively recruited during lengthening contractions? Review and applications to sport movements. Sports Biomech 7: 137–157, 2008.
27. Chan MHS, Carey AL, Watt MJ, Febbraio MA. Cytokine gene expression in human skeletal muscle during concentric contraction: Evidence that IL-8, like IL-6, is influenced by glycogen availability. Am J Physiol Regul Integr Comp Physiol 287: 322–327, 2004.
28. Chen TC, Lin K, Chen H, Lin M, Nosaka K. Comparison in eccentric exercise
-induced muscle damage among four limb muscles. Eur J Appl Physiol 111: 211–223, 2011.
29. Clarke MS, Bamman MM, Feeback DL. Bed rest decreases mechanically induced myofiber wounding and consequent wound-mediated FGF release. J Appl Physiol 85: 593–600, 1998.
30. Clarke MS, Feeback DL. Mechanical load induces sarcoplasmic wounding and FGF release in differentiated human skeletal muscle cultures. FASEB J 10: 502–509, 1996.
31. Clarkson PM, Byrnes WC, McCormick KM, Turcotte LP, White JS. Muscle soreness and serum creatine kinase activity following isometric, eccentric, and concentric exercise. Int J Sports Med 7: 152–155, 1986.
32. Clarkson PM, Hubal MJ. Exercise-induced muscle damage in humans. Am J Phys Med Rehabil 81: 52–69, 2002.
33. Clarkson PM, Nosaka K, Braun B. Muscle function after exercise-induced muscle damage and rapid adaptation. Med Sci Sports Exerc 24: 512–520, 1992.
34. Cornelison DD, Wold BJ. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev Biol 191: 270–283, 1997.
35. Croisier JL, Camus G, Venneman I, Deby-Dupont G, Juchmes-Ferir A, Lamy M, Crielaard JM, Deby C, Duchateau J. Effects of training on exercise-induced muscle damage and interleukin 6 production. Muscle Nerve 22: 208–212, 1999.
36. Dangott B, Schultz E, Mozdziak PE. Dietary creatine monohydrate supplementation increases satellite cell mitotic activity during compensatory hypertrophy. Int J Sports Med 21: 13–16, 2000.
37. De Filippis E, Alvarez G, Berria R, Cusi K, Everman S, Meyer C, Mandarino LJ. Insulin-resistant muscle is exercise resistant: evidence for reduced response of nuclear-encoded mitochondrial genes to exercise. Am J Physiol Endocrinol Metab 294: 607–614, 2008.
38. Dhawan J, Rando TA. Stem cells in postnatal myogenesis: Molecular mechanisms of satellite cell quiescence, activation and replenishment. Trends Cell Biol 15: 666–673, 2005.
39. Dreyer HC, Fujita S, Cadenas JG, Chinkes DL, Volpi E, Rasmussen BB. Resistance exercise increases AMPK activity and reduces 4E-BP1 phosphorylation and protein synthesis in human skeletal muscle. J Physiol (Lond) 576: 613–624, 2006.
40. Dunn SE, Chin ER, Michel RN. Matching of calcineurin activity to upstream effectors is critical for skeletal muscle fiber growth. J Cell Biol 151: 663–672, 2000.
41. Ebbeling CB, Clarkson PM. Exercise-induced muscle damage and adaptation. Sports Med 7: 207–234, 1989.
42. Eliasson J, Elfegoun T, Nilsson J, Kohnke R, Ekblom B, Blomstrand E. Maximal lengthening contractions increase p70 S6 kinase phosphorylation in human skeletal muscle in the absence of nutritional supply. Am J Physiol Endocrinol Metab 291: 1197–1205, 2006.
43. Enoka RM. Eccentric contractions require unique activation strategies by the nervous system. J Appl Physiol 81: 2339–2346, 1996.
44. Evans WJ, Cannon JG. The metabolic effects of exercise-induced muscle damage. Exerc Sport Sci Rev 19: 99–9125, 1991.
45. Febbraio MA, Pedersen BK. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 16: 1335–1347, 2002.
46. Flann KL, LaStayo PC, McClain DA, Hazel M, Lindstedt SL. Muscle damage and muscle remodeling: no pain, no gain? J Exp Biol 214: 674–679, 2011.
47. Formigli L, Lombardo LD, Adembri C, Brunelleschi S, Ferrari E, Novelli GP. Neutrophils as mediators of human skeletal muscle ischemia-reperfusion syndrome. Hum Pathol 23: 627–634, 1992.
48. Fry AC. The role of resistance exercise intensity on muscle fibre adaptations. Sports Med 34: 663–679, 2004.
49. Garma T, Kobayashi C, Haddad F, Adams GR, Bodell PW, Baldwin KM. Similar acute molecular responses to equivalent volumes of isometric, lengthening, or shortening mode resistance exercise. J Appl Physiol 102: 135–143, 2007.
50. Gibala MJ, Interisano SA, Tarnopolsky MA, Roy BD, MacDonald JR, Yarasheski KE, MacDougall JD. Myofibrillar disruption following acute concentric and eccentric resistance exercise in strength-trained men. Can J Physiol Pharmacol 78: 656–661, 2000.
51. Gibala MJ, MacDougall JD, Tarnopolsky MA, Stauber WT, Elorriaga A. Changes in human skeletal muscle ultrastructure and force production after acute resistance exercise. J Appl Physiol 78: 702–708, 1995.
52. Gibala MJ, McGee SL, Garnham AP, Howlett KF, Snow RJ, Hargreaves M. Brief intense interval exercise activates AMPK and p38 MAPK signaling and increases the expression of PGC-1alpha in human skeletal muscle. J Appl Physiol 106: 929–934, 2009.
53. Gomez-Cabrera MC, Domenech E, Vina J. Moderate exercise is an antioxidant: Upregulation of antioxidant genes by training. Free Radic Biol Med 44: 126–131, 2008.
54. Goodman CA, Frey JW, Mabrey DM, Jacobs BL, Lincoln HC, You J, Hornberger TA. The role of skeletal muscle mTOR in the regulation of mechanical load-induced growth. J Physiol (Lond ) 589: 5485–5501, 2011.
55. Grabiner MD, Owings TM, George MR, Enoka RM. Eccentric contractions are specified a priori by the CNS. Proceedings of the VXth Congress of the International Society of Biomechanics; July 2–6, 1995; Jyvaskyla, Finland. pp. 338–339.
56. Grant AC, Gow IF, Zammit VA, Shennan DB. Regulation of protein synthesis in lactating rat mammary tissue by cell volume. Biochim Biophys Acta 1475: 39–46, 2000.
57. Gute DC, Ishida T, Yarimizu K, Korthuis RJ. Inflammatory responses to ischemia and reperfusion in skeletal muscle. Mol Cell Biochem 179: 169–187, 1998.
58. Guyton A. Textbook of Medical Physiology. Philadelphia, PA: WB Saunders, 1986. pp. 366–368.
59. Haddad F, Adams GR. Inhibition of MAP/ERK kinase prevents IGF-I-induced hypertrophy in rat muscles. J Appl Physiol 96: 203–210, 2004.
60. Hameed M, Lange KH, Andersen JL, Schjerling P, Kjaer M, Harridge SD, Goldspink G. The effect of recombinant human growth hormone and resistance training on IGF-I mRNA expression in the muscles of elderly men. J Physiol 555: 231–240, 2004.
61. Handayaningsih A, Iguchi G, Fukuoka H, Nishizawa H, Takahashi M, Yamamoto M, Herningtyas E, Okimura Y, Kaji H, Chihara K, Seino S, Takahashi Y. Reactive oxygen species play an essential role in IGF-I signaling and IGF-I-induced myocyte hypertrophy in C2C12 myocytes. Endocrinology 152: 912–921, 2011.
62. Hather BM, Tesch PA, Buchanan P, Dudley GA. Influence of eccentric actions on skeletal muscle adaptations to resistance training. Acta Physiol Scand 143: 177–185, 1991.
63. Haussinger D. The role of cellular hydration in the regulation of cell function. Biochem J 313(Pt 3): 697–710, 1996.
64. Hawke TJ, Garry DJ. Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 91: 534–551, 2001.
65. Hawley JA. Molecular responses to strength and endurance training: Are they incompatible? Appl Physiol Nutr Metab 34: 355–361, 2009.
66. Hill M, Goldspink G. Expression and splicing of the insulin-like growth factor gene in rodent muscle is associated with muscle satellite (stem) cell activation following local tissue damage. J Physiol (Lond) 549: 409–418, 2003.
67. Hill M, Wernig A, Goldspink G. Muscle satellite (stem) cell activation during local tissue injury and repair. J Anat 203: 89–99, 2003.
68. Hornberger TA, Chu WK, Mak YW, Hsiung JW, Huang SA, Chien S. The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skeletal muscle. Proc Natl Acad Sci USA 103: 4741–4746, 2006.
69. Hornberger TA, McLoughlin TJ, Leszczynski JK, Armstrong DD, Jameson RR, Bowen PE, Hwang ES, Hou H, Moustafa ME, Carlson BA, Hatfield DL, Diamond AM, Esser KA. Selenoprotein-deficient transgenic mice exhibit enhanced exercise-induced muscle growth. J Nutr 133: 3091–3097, 2003.
70. Hornberger TA, Stuppard R, Conley KE, Fedele MJ, Fiorotto ML, Chin ER, Esser KA. Mechanical stimuli regulate rapamycin-sensitive signalling by a phosphoinositide 3-kinase-, protein kinase B- and growth factor-independent mechanism. Biochem J 380: 795–804, 2004.
71. Howatson G, Milak A. Exercise-induced muscle damage following a bout of sport specific repeated sprints. J Strength Cond Res 23: 2419–2424, 2009.
72. Howell JN, Chleboun G, Conatser R. Muscle stiffness, strength loss, swelling and soreness following exercise-induced injury in humans. J Physiol (Lond) 464: 183–196, 1993.
73. Howell JN, Fuglevand AJ, Walsh ML, Bigland-Ritchie B. Motor unit activity during isometric and concentric-eccentric contractions of the human first dorsal interosseus muscle. J Neurophysiol 74: 901–904, 1995.
74. Hulmi JJ, Walker S, Ahtiainen JP, Nyman K, Kraemer WJ, Hakkinen K. Molecular signaling in muscle is affected by the specificity of resistance exercise protocol. Scand J Med Sci Sports, 2010 . doi: 10.1111/j.1600-0838.2010.01198.x. [Epub ahead of print].
75. Jacinto E, Hall MN. Tor signalling in bugs, brain and brawn. Nat Rev Mol Cell Biol 4: 117–126, 2003.
76. Jackson MJ. Free radicals generated by contracting muscle: by-products of metabolism or key regulators of muscle function? Free Radic Biol Med 44: 132–141, 2008.
77. Ji LL, Gomez-Cabrera MC, Vina J. Exercise and hormesis: Activation of cellular antioxidant signaling pathway. Ann NY Acad Sci 1067: 425–435, 2006.
78. Kefaloyianni E, Gaitanaki C, Beis I. ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-kappaB transactivation during oxidative stress in skeletal myoblasts. Cell Signal 18: 2238–2251, 2006.
79. Koh TJ, Pizza FX. Do inflammatory cells influence skeletal muscle hypertrophy? Front Biosci (Elite Ed) 1: 60–71, 2009.
80. Komulainen J, Kalliokoski R, Koskinen SO, Drost MR, Kuipers H, Hesselink MK. Controlled lengthening or shortening contraction-induced damage is followed by fiber hypertrophy in rat skeletal muscle. Int J Sports Med 21: 107–112, 2000.
81. Kosek DJ, Kim JS, Petrella JK, Cross JM, Bamman MM. Efficacy of 3 days/wk resistance training on myofiber hypertrophy and myogenic mechanisms in young vs. older adults. J Appl Physiol 101: 531–544, 2006.
82. Kraemer WJ, Adams K, Cafarelli E, Dudley GA, Dooly C, Feigenbaum MS, Fleck SJ, Franklin B, Fry AC, Hoffman JR, Newton RU, Potteiger J, Stone MH, Ratamess NA, Triplett-McBride T, and American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Med Sci Sports Exerc 34: 364–380, 2002.
83. Krentz JR, Farthing JP. Neural and morphological changes in response to a 20-day intense eccentric training protocol. Eur J Appl Physiol 110: 333–340, 2010.
84. Kuipers H. Exercise-induced muscle damage. Int J Sports Med 15: 132–135, 1994.
85. Lang F. Mechanisms and significance of cell volume regulation. J Am Coll Nutr 26: 613S–623S, 2007.
86. LaStayo P, McDonagh P, Lipovic D, Napoles P, Bartholomew A, Esser K, Lindstedt S. Elderly patients and high force resistance exercise—A descriptive report: Can an anabolic, muscle growth response occur without muscle damage or inflammation? J Geriatr Phys Ther 30: 128–134, 2007.
87. Low SY, Rennie MJ, Taylor PM. Signaling elements involved in amino acid transport responses to altered muscle cell volume. FASEB J. 11: 1111–1117, 1997.
88. Lynn R, Morgan DL. Decline running produces more sarcomeres in rat vastus intermedius muscle fibers than does incline running. J Appl Physiol 77: 1439–1444, 1994.
89. Lynn R, Talbot JA, Morgan DL. Differences in rat skeletal muscles after incline and decline running. J Appl Physiol 85: 98–104, 1998.
90. MacDougall JD, Sale DG, Alway SE, Sutton JR. Muscle fiber number in biceps brachii in bodybuilders and control subjects. J Appl Physiol 57: 1399–1403, 1984.
91. Mackey AL, Kjaer M, Dandanell S, Mikkelsen KH, Holm L, Dossing S, Kadi F, Koskinen SO, Jensen CH, Schroder HD, Langberg H. The influence of anti-inflammatory medication on exercise-induced myogenic precursor cell responses in humans. J Appl Physiol 103: 425–431, 2007.
92. MacNeil LG, Melov S, Hubbard AE, Baker SK, Tarnopolsky MA. Eccentric exercise
activates novel transcriptional regulation of hypertrophic signaling pathways not affected by hormone changes. PLoS One 5: e10695, 2010.
93. Malm C. Exercise-induced muscle damage and inflammation: Fact or fiction? Acta Physiol Scand 171: 233–239, 2001.
94. Martineau LC, Gardiner PF. Insight into skeletal muscle mechanotransduction: MAPK activation is quantitatively related to tension. J Appl Physiol 91: 693–702, 2001.
95. Mayhew TP, Rothstein JM, Finucane SD, Lamb RL. Muscular adaptation to concentric and eccentric exercise
at equal power levels. Med Sci Sports Exerc 27: 868–873, 1995.
96. McGinley C, Shafat A, Donnelly AE. Does antioxidant vitamin supplementation protect against muscle damage? Sports Med 39: 1011–1032, 2009.
97. McHugh MP. Recent advances in the understanding of the repeated bout effect: The protective effect against muscle damage from a single bout of eccentric exercise
. Scand J Med Sci Sports 13: 88–97, 2003.
98. McKay BR, O'Reilly CE, Phillips SM, Tarnopolsky MA, Parise G. Co-expression of IGF-1 family members with myogenic regulatory factors following acute damaging muscle-lengthening contractions in humans. J Physiol 586: 5549–5560, 2008.
99. Michel RN, Dunn SE, Chin ER. Calcineurin and skeletal muscle growth. Proc Nutr Soc 63: 341–349, 2004.
100. Mikkelsen UR, Langberg H, Helmark IC, Skovgaard D, Andersen LL, Kjaer M, Mackey AL. Local NSAID infusion inhibits satellite cell proliferation in human skeletal muscle after eccentric exercise
. J Appl Physiol 107: 1600–1611, 2009.
101. Millar ID, Barber MC, Lomax MA, Travers MT, Shennan DB. Mammary protein synthesis is acutely regulated by the cellular hydration state. Biochem Biophys Res Commun 230: 351–355, 1997.
102. Miyazaki M, McCarthy JJ, Fedele MJ, Esser KA. Early activation of mTORC1 signalling in response to mechanical overload is independent of phosphoinositide 3-kinase/Akt signalling. J Physiol 589: 1831–1846, 2011.
103. Moore DR, Young M, Phillips SM. Similar increases in muscle size and strength in young men after training with maximal shortening or lengthening contractions when matched for total work. Eur J Appl Physiol, 2011.
104. Moss FP, Leblond CP. Satellite cells as the source of nuclei in muscles of growing rats. Anat Rec 170: 421–435, 1971.
105. Musaro A, McCullagh KJ, Naya FJ, Olson EN, Rosenthal N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 400: 581–585, 1999.
106. Nader GA. Molecular determinants of skeletal muscle mass: Getting the “AKT” together. Int J Biochem Cell Biol 37: 1985–1996, 2005.
107. Nardone A, Romano C, Schieppati M. Selective recruitment of high-threshold human motor units during voluntary isotonic lengthening of active muscles. J Physiol (Lond) 409: 451–471, 1989.
108. Nardone A, Schieppati M. Shift of activity from slow to fast muscle during voluntary lengthening contractions of the triceps surae muscles in humans. J Physiol (Lond) 395: 363–381, 1988.
109. Nguyen HX, Tidball JG. Null mutation of gp91phox reduces muscle membrane lysis during muscle inflammation in mice. J Physiol (Lond) 553: 833–841, 2003.
110. Nielsen AR, Pedersen BK. The biological roles of exercise-induced cytokines: IL-6, IL-8, and IL-15. Appl Physiol Nutr Metab 32: 833–839, 2007.
111. Nosaka K, Clarkson PM. Changes in indicators of inflammation after eccentric exercise
of the elbow flexors. Med Sci Sports Exerc 28: 953–961, 1996.
112. Nosaka K, Lavender A, Newton M, Sacco P. Muscle damage in resistance training: Is muscle damage necessary for strength gain and muscle hypertrophy? IJSHS 1: 1–8, 2003.
113. O'Neil TK, Duffy LR, Frey JW, Hornberger TA. The role of phosphoinositide 3-kinase and phosphatidic acid in the regulation of mammalian target of rapamycin following eccentric contractions. J Physiol 587: 3691–3701, 2009.
114. Owino V, Yang SY, Goldspink G. Age-related loss of skeletal muscle function and the inability to express the autocrine form of insulin-like growth factor-1 (MGF) in response to mechanical overload. FEBS Lett 505: 259–263, 2001.
115. Parsons SA, Millay DP, Wilkins BJ, Bueno OF, Tsika GL, Neilson JR, Liberatore CM, Yutzey KE, Crabtree GR, Tsika RW, Molkentin JD. Genetic loss of calcineurin blocks mechanical overload-induced skeletal muscle fiber type switching but not hypertrophy. J Biol Chem 279: 26192–26200, 2004.
116. Paul AC, Rosenthal N. Different modes of hypertrophy in skeletal muscle fibers. J Cell Biol 156: 751–760, 2002.
117. Paulsen G, Egner IM, Drange M, Langberg H, Benestad HB, Fjeld JG, Hallen J, Raastad T. A. COX-2 inhibitor reduces muscle soreness, but does not influence recovery and adaptation after eccentric exercise
. Scand J Med Sci Sports 20: e195–e207, 2010.
118. Pedersen BK, Ostrowski K, Rohde T, Bruunsgaard H. The cytokine response to strenuous exercise. Can J Physiol Pharmacol 76: 505–511, 1998.
119. Petrella JK, Kim J, Mayhew DL, Cross JM, Bamman MM. Potent myofiber hypertrophy during resistance training in humans is associated with satellite cell-mediated myonuclear addition: a cluster analysis. J Appl Physiol 104: 1736–1742, 2008.
120. Proske U, Morgan DL. Muscle damage from eccentric exercise
: Mechanism, mechanical signs, adaptation and clinical applications. J Physiol 537: 333–345, 2001.
121. Quinn LS. Interleukin-15: A muscle-derived cytokine regulating fat-to-lean body composition. J Anim Sci 86: E75–E83, 2008.
122. Riechman SE, Balasekaran G, Roth SM, Ferrell RE. Association of interleukin-15 protein and interleukin-15 receptor genetic variation with resistance exercise training responses. J Appl Physiol 97: 2214–2219, 2004.
123. Roig M, O'Brien K, Kirk G, Murray R, McKinnon P, Shadgan B, Reid WD. The effects of eccentric versus concentric resistance training on muscle strength and mass in healthy adults: A systematic review with meta-analysis. Br J Sports Med 43: 556–568, 2009.
124. Rosenblatt JD, Yong D, Parry DJ. Satellite cell activity is required for hypertrophy of overloaded adult rat muscle. Muscle Nerve 17: 608–613, 1994.
125. Russ DW, Towse TF, Wigmore DM, Lanza IR, Kent-Braun JA. Contrasting influences of age and sex on muscle fatigue. Med Sci Sports Exerc 40: 234–241, 2008.
126. Russell B, Dix DJ, Haller DL, Jacobs-El J. Repair of injured skeletal muscle: a molecular approach. Med Sci Sports Exerc 24: 189–196, 1992.
127. Sabourin LA, Rudnicki MA. The molecular regulation of myogenesis. Clin Genet 57: 16–25, 2000.
128. Sakuma K, Yamaguchi A. The functional role of calcineurin in hypertrophy, regeneration, and disorders of skeletal muscle. J Biomed Biotechnol 2010: 721219, 2010.
129. Saxton JM, Donnelly AE, Roper HP. Indices of free-radical-mediated damage following maximum voluntary eccentric and concentric muscular work. Eur J Appl Physiol Occup Physiol 68: 189–193, 1994.
130. Schoenfeld BJ. The mechanisms of muscle hypertrophy and their application to resistance training. J Strength Cond Res 24: 2857–2872, 2010.
131. Schultz E, Jaryszak DL, Valliere CR. Response of satellite cells to focal skeletal muscle injury. Muscle Nerve 8: 217–222, 1985.
132. Schwane JA, Johnson SR, Vandenakker CB, Armstrong RB. Delayed-onset muscular soreness and plasma CPK and LDH activities after downhill running. Med Sci Sports Exerc 15: 51–56, 1983.
133. Semsarian C, Wu MJ, Ju YK, Marciniec T, Yeoh T, Allen DG, Harvey RP, Graham RM. Skeletal muscle hypertrophy is mediated by a Ca2+
-dependent calcineurin signalling pathway. Nature 400: 576–581, 1999.
134. Serrano AL, Baeza-Raja B, Perdiguero E, Jardi M, Munoz-Canoves P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab 7: 33–44, 2008.
135. Seynnes OR, de Boer M, Narici MV. Early skeletal muscle hypertrophy and architectural changes in response to high-intensity resistance training. J Appl Physiol 102: 368–373, 2007.
136. Sinha-Hikim I, Cornford M, Gaytan H, Lee ML, Bhasin S. Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community-dwelling older men. J Clin Endocrinol Metab 91: 3024–3033, 2006.
137. Soltow QA, Betters JL, Sellman JE, Lira VA, Long JHD, Criswell DS. Ibuprofen inhibits skeletal muscle hypertrophy in rats. Med Sci Sports Exerc 38: 840–846, 2006.
138. Spangenburg EE. Changes in muscle mass with mechanical load: Possible cellular mechanisms. Appl Physiol Nutr Metab 34: 328–335, 2009.
139. Stoll BA, Secreto G. Prenatal influences and breast cancer. Lancet 340: 1478, 1992.
140. Suzuki YJ, Ford GD. Redox regulation of signal transduction in cardiac and smooth muscle. J Mol Cell Cardiol 31: 345–353, 1999.
141. Takarada Y, Nakamura Y, Aruga S, Onda T, Miyazaki S, Ishii N. Rapid increase in plasma growth hormone after low-intensity resistance exercise with vascular occlusion. J Appl Physiol 88: 61–65, 2000.
142. Tannerstedt J, Apro W, Blomstrand E. Maximal lengthening contractions induce different signaling responses in the type I and type II fibers of human skeletal muscle. J Appl Physiol 106: 1412–1418, 2009.
143. Tatsumi R, Hattori A, Ikeuchi Y, Anderson JE, Allen RE. Release of hepatocyte growth factor from mechanically stretched skeletal muscle satellite cells and role of pH and nitric oxide. Mol Biol Cell 13: 2909–2918, 2002.
144. Tee JC, Bosch AN, Lambert MI. Metabolic consequences of exercise-induced muscle damage. Sports Med. 37: 827–836, 2007.
145. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279: L1005–L1028, 2000.
146. Thomas G, Hall MN. TOR signalling and control of cell growth. Curr Opin Cell Biol 9: 782–787, 1997.
147. Tidball JG. Mechanical signal transduction in skeletal muscle growth and adaptation. J Appl Physiol 98: 1900–1908, 2005.
148. Tidball JG. Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol 288: 345–353, 2005.
149. Timmons JA. Variability in training-induced skeletal muscle adaptation. J Appl Physiol 110: 846–853, 2011.
150. Toft AD, Jensen LB, Bruunsgaard H, Ibfelt T, Halkjaer-Kristensen J, Febbraio M, Pedersen BK. Cytokine response to eccentric exercise
in young and elderly humans. Am J Physiol Cell Physiol 283: 289–295, 2002.
151. Toigo M, Boutellier U. New fundamental resistance exercise determinants of molecular and cellular muscle adaptations. Eur J Appl Physiol 97: 643–663, 2006.
152. Trappe TA, Raue U, Tesch PA. Human soleus muscle protein synthesis following resistance exercise. Acta Physiol Scand 182: 189–196, 2004.
153. Trappe TA, White F, Lambert CP, Cesar D, Hellerstein M, Evans WJ. Effect of ibuprofen and acetaminophen on postexercise muscle protein synthesis. Am J Physiol Endocrinol Metab 282: E551–E556, 2002.
154. Treebak JT, Birk JB, Rose AJ, Kiens B, Richter EA, Wojtaszewski JFP. AS160 phosphorylation is associated with activation of alpha2beta2gamma1- but not alpha2beta2gamma3-AMPK trimeric complex in skeletal muscle during exercise in humans. Am J Physiol Endocrinol Metab 292: 715–722, 2007.
155. Uchiyama S, Tsukamoto H, Yoshimura S, Tamaki T. Relationship between oxidative stress in muscle tissue and weight-lifting-induced muscle damage. Pflugers Arch 452: 109–116, 2006.
156. Velloso CP. Regulation of muscle mass by growth hormone and IGF-I. Br J Pharmacol 154: 557–568, 2008.
157. Vierck J, O'Reilly B, Hossner K, Antonio J, Byrne K, Bucci L, Dodson M. Satellite cell regulation following myotrauma caused by resistance exercise. Cell Biol Int 24: 263–272, 2000.
158. Vijayan K, Thompson JL, Norenberg KM, Fitts RH, Riley DA. Fiber-type susceptibility to eccentric contraction-induced damage of hindlimb-unloaded rat AL muscles. J Appl Physiol 90: 770–776, 2001.
159. Wang XD, Kawano F, Matsuoka Y, Fukunaga K, Terada M, Sudoh M, Ishihara A, Ohira Y. Mechanical load-dependent regulation of satellite cell and fiber size in rat soleus muscle. Am J Physiol Cell Physiol 290: 981–989, 2006.
160. Wernig A, Irintchev A, Weisshaupt P. Muscle injury, cross-sectional area and fibre type distribution in mouse soleus after intermittent wheel-running. J Physiol 428: 639–652, 1990.
161. Yablonka-Reuveni Z, Seger R, Rivera AJ. Fibroblast growth factor promotes recruitment of skeletal muscle satellite cells in young and old rats. J Histochem Cytochem 47: 23–42, 1999.
162. Yamada S, Buffinger N, DiMario J, Strohman RC. Fibroblast growth factor is stored in fiber extracellular matrix and plays a role in regulating muscle hypertrophy. Med Sci Sports Exerc 21: 173–180, 1989.
163. Yang SY, Goldspink G. Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. FEBS Lett. 522: 156–160, 2002.
164. Yu JG, Furst DO, Thornell LE. The mode of myofibril remodelling in human skeletal muscle affected by DOMS induced by eccentric contractions. Histochem Cell Biol 119: 383–393, 2003.
165. Zammit PS. All muscle satellite cells are equal, but are some more equal than others? J Cell Sci 121: 2975–2982, 2008.